| Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647) |
|---|
| 05/16/2006 | US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents |
| 05/11/2006 | WO2006050097A1 Substituted phenylalkanoic acids |
| 05/11/2006 | WO2005123646A3 Fluoroorganic compounds and anti-fouling treatments |
| 05/11/2006 | US20060100460 Substituted N-sulfonylaminobenzyl-2-phenoxyacetamide compounds as VR1 receptor agonists |
| 05/11/2006 | US20060100289 Nitrone compounds, pharmaceutical compositions containing the same and methods for treating inflammation and neuropathic pain |
| 05/11/2006 | US20060100283 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof |
| 05/11/2006 | US20060100251 Substituted phenylalkanoic acids |
| 05/11/2006 | CA2585555A1 Substituted phenylalkanoic acids |
| 05/10/2006 | EP1654221A2 Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators |
| 05/10/2006 | EP1212296B9 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 05/10/2006 | CN1769266A Process for preparing biphenyl compounds |
| 05/09/2006 | US7041691 E.g., 2-(2,6-Dichloro-4-nitro-phenylsulfanyl)-benzothiazole-5-carboxylic acid methyl ester; modulators of peroxisome proliferator-activated receptors (PPARs) to treat type 11 diabetes and obesity; hypertension, hyperlipidemia, hypercholesterolemia, and hyperlipoproteinemia; antiinflammatory agents |
| 05/09/2006 | US7041670 Florfenicol-type antibiotics |
| 05/09/2006 | CA2163336C Ionic conducting material having good anticorrosive properties |
| 05/09/2006 | CA2125105C Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 05/04/2006 | WO2006047302A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
| 05/04/2006 | WO2006046916A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | WO2006046593A1 Benzene compound having 2 or more substituents |
| 05/04/2006 | WO2006045554A1 (biphenyl) carboxylic acids and derivatives thereof |
| 05/04/2006 | WO2006045498A1 Sulfonamido compounds that antagonise the vanilloid trpv1 receptor |
| 05/04/2006 | US20060094721 Sulfonamides as potassium channel blockers |
| 05/04/2006 | US20060094708 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 05/04/2006 | CA2584664A1 (biphenyl) carboxylic acids and derivatives thereof |
| 05/04/2006 | CA2584413A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | CA2580690A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
| 05/03/2006 | EP1651595A2 Ubiquitin ligase inhibitors |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1194404B1 Inhibitors of aspartyl protease |
| 05/03/2006 | EP1107951B8 Homo- or copolymeric material based on sulfonylimides possessing a polymerizable group |
| 05/03/2006 | CN1768026A 2-aryl-acetic acids, their derivatives and pharmaceutical compositions containing them |
| 05/03/2006 | CN1767823A Asthma and allergic inflammation modulators |
| 05/03/2006 | CN1254465C Calcilytic compounds |
| 05/02/2006 | USRE39088 Amide compounds and use of the same |
| 05/02/2006 | US7038084 Viricides; Aids therapy |
| 05/02/2006 | CA2250426C Amidinohydrazones as protease inhibitors |
| 04/27/2006 | WO2006042678A1 Method for cleaning 3-hydroxyamidinophenylalanine derivatives by the precipitation and recrystallisation of a salt and an aromatic sulphonic acid |
| 04/27/2006 | US20060089336 4-Dedimethylamino tetracycline compounds |
| 04/27/2006 | US20060089334 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 04/27/2006 | CA2583771A1 Method for cleaning 3-hydroxyamidinophenylalanine derivatives by the precipitation and recrystallization of salt and an aromatic sulfonic acid |
| 04/26/2006 | EP1648861A1 Process for the preparation of cpla 2 inhibitors |
| 04/26/2006 | CN1762993A Chiral sulfonamide-aminol ligand and preparation method and uses |
| 04/25/2006 | US7034182 Compounds to treat Alzheimer's disease |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034056 Aryl and biaryl compounds having MCH modulatory activity |
| 04/25/2006 | US7034045 Monofluoroalkyl derivatives |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034015 Interleukin 1 beta and tumour necrosis factor alpha inhibitors |
| 04/20/2006 | WO2006041119A1 Hydrazide derivatives |
| 04/20/2006 | WO2006040179A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | WO2006040177A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 recptor |
| 04/20/2006 | WO2005113513A3 Aryl sulfonamides |
| 04/20/2006 | US20060084699 Antagonists of the B2 receptor of bradykinin; analgesics; hyperalgesia and major algesia; cancer; nontoxic; industrial scale; 5-[[(2,4-dichloro-3-methylphenyl)sulphonyl]methylamino]-N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-N-methyl-pentanamide |
| 04/20/2006 | US20060084641 IL-8 receptor antagonists |
| 04/20/2006 | US20060084613 Dipeptide enzyme inhibitor; antiinflammatory agents; autoimmune disease; wound healing agents |
| 04/20/2006 | CA2583967A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/20/2006 | CA2583918A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/19/2006 | EP1064274B1 Benzenesulfonamide derivatives and their use as medicaments |
| 04/19/2006 | CN1761645A Sulfonic acids, their derivatives and pharmaceutical compositions containing them |
| 04/19/2006 | CN1760178A Full halothane sulfonic acid salts, preparation method and application |
| 04/19/2006 | CN1252047C Benzene sulfonic derivative |
| 04/18/2006 | US7030160 An agonist as beta-3 adrenergic receptors; chemical intermediates preparing through decyclization, hydroxylation; for treating gastrointestinal diseases, obesity, diabetics, psychotropic agents, nervous system disorders |
| 04/18/2006 | US7030067 For phosphate ester hydraulic fluids used in conditions under which hydrocarbon surfactants would degrade |
| 04/13/2006 | WO2006038606A1 Biaryl derivative |
| 04/13/2006 | WO2006038594A1 N-type calcium channel inhibitor |
| 04/13/2006 | WO2005007621A3 Ubiquitin ligase inhibitors |
| 04/13/2006 | US20060079714 Mixing R(-)-1,1'-binaphthyl-2,2'-diyl-hydrogen phosphate and tamsulosin in an organic solvent to form a solid R-tamsulosin-S-BPA salt, filtering, basifiying, isolating the solid R-tamsulosin free base by extraction, converting the R-tamsulosin free base to a pharmaceutically acceptable salt |
| 04/13/2006 | US20060079696 Substituted compounds derived from N-(benzyl)phenylacetamide, preparation and uses |
| 04/12/2006 | EP1644326A1 Cathepsin cysteine protease inhibitors |
| 04/12/2006 | EP1644325A2 Methods and compositions for treating amyloid-related diseases |
| 04/12/2006 | EP1644324A1 Process for preparing acylsulfamoylbenzamides |
| 04/12/2006 | EP1644025A1 Water-soluble shps as novel alkylating agents |
| 04/12/2006 | EP1643986A2 Phenylcarboxylate beta-secretase inhibitors for the treatment of alzheimer s disease |
| 04/12/2006 | EP1643960A2 Arylsulfonamide derivatives |
| 04/12/2006 | EP1643958A2 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 04/12/2006 | EP1343771B1 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors |
| 04/12/2006 | CN1757635A 4-hydroxy valeramide compounds, prepn. method and use thereof |
| 04/12/2006 | CN1250519C Amine derivative with K channel regulation function and its preparing process and application |
| 04/12/2006 | CN1250518C Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application |
| 04/12/2006 | CN1250209C Inhibitor for 20-hydroxy-eicosatetraenoic acid enzyme |
| 04/11/2006 | US7026419 Adhesives and sealants |
| 04/11/2006 | US7026339 Inhibitors of HCV NS5B polymerase |
| 04/11/2006 | CA2155013C C2 taxane derivatives and pharmaceutical compositions containing them |
| 04/11/2006 | CA2089440C Ortho-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicaments containing them |
| 04/11/2006 | CA2089439C 3,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them |
| 04/06/2006 | WO2006036670A1 Sulfonamide compounds |
| 04/06/2006 | WO2006036664A1 Substituted sulfonamidopropionamides and methods of use |
| 04/06/2006 | US20060074238 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates |
| 04/06/2006 | US20060074111 Chemical compounds |
| 04/06/2006 | CA2581426A1 Sulfonamide compounds |
| 04/06/2006 | CA2580461A1 Substituted sulfonamidopropionamides and methods of use |
| 04/05/2006 | EP1642888A1 compounds for modulating the rage receptor |
| 04/05/2006 | EP1641748A2 N-alkyl phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer s disease |
| 04/05/2006 | EP1641745A1 Propionamide derivatives useful as androgen receptor modulators |
| 04/05/2006 | EP1641742A2 Compounds that selectively bind to membranes of apoptotic cells |
| 04/05/2006 | EP1453777B1 Functionalized higher diamondoids |
| 04/05/2006 | EP1140846B1 Aspartic protease inhibitors |
| 04/05/2006 | CN1756760A Process for the preparation of anticonvulsant derivatives |
| 04/05/2006 | CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases |
| 04/05/2006 | CN1249025C Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
| 04/05/2006 | CN1249020C Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof |